Previous 10 | Next 10 |
Recent news releases related news releases and press releases from 11/08/23 07:00:26 on US and Canada Markets.
Third quarter revenues of $59.2 million, in line with previous guidance Third quarter GAAP net loss of $8.2 million; non-GAAP net loss of $3.4 million Impressions and consumables revenues both continued to grow year-over-year System sales increased quarter-over-quarter on continued co...
YAVNE, Israel, and DENKENDORF, Germany, Nov. 08, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD), a fully-integrated biopharmaceutical company focused on next-generation enzymatic therapeutics for tissue repair, and PolyMedics Innovations (PMI), an innovative biomaterials company specializ...
REHOVOT, Israel, and HOBOKEN, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a commercial stage global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, toda...
Net cash provided by operating activities (GAAP) of $574 million and Adjusted Cash Receipts ( 1) (non-GAAP) of $637 million Announced transactions of up to $3.8 billion year-to-date, including $2.1 billion in upfront payments Raising 2023 guidance: Adjusted C...
Net cash provided by operating activities (GAAP) of $574 million and Adjusted Cash Receipts ( 1) (non-GAAP) of $637 million Announced transactions of up to $3.8 billion year-to-date, including $2.1 billion in upfront payments Raising 2023 guidance: Adjusted C...
RADCOM Reports Third Quarter 2023 Results PR Newswire Record quarterly revenue of $13.2 million Significantly improved profitability 17th consecutive quarter of year-over-year revenue growth On track to exceed $50 million annual revenue TEL AVIV, ...
Q3 Consolidated Net Revenue Drives Operating Income of $94 Million, Net Income of $8 Million, Consolidated Adjusted EBITDA of $236 Million and Attributable Free Cash Flow of $100 Million Quarterly and Nine Month Return of Capital to Shareholders of $246 Million and $659 Million, Respectiv...
Commercial launch of INPEFA ® (sotagliflozin) as a differentiated, new treatment option for heart failure patients shows meaningful progress in Q3 with increasing demand across the cardiology community Significant formulary inclusions effective in Q4 opening...
IDEXX Expands SNAP Platform with Leish 4Dx Test to Support Veterinarians Globally in Diagnosing Vector-borne Diseases PR Newswire The rapid diagnostic test provides a comprehensive solution for detecting canine leishmaniosis that impacts one in 10 dogs in endemic regions ...
3Q 2023 Total Revenue of $103.5M, a 27% Increase Year-Over-Year and 22% at CER Galafol d ® Quarterly Revenue Surpasses $100M for the First Time Increasing FY 2023 Galafol d ® Revenue Growth Guidance to 16%...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
14.77%Change Percent:
Nuvve Holding Corp. Company Name:
NVVE Stock Symbol:
NASDAQ Market:
nuvve.com Website: